Aerogen, an Irish Success Story

Aerogen is a global leader in the development of inhalation drug delivery systems. The company was founded in 1997 by John Power and John Geraghty, who were both working in the pharmaceutical industry at the time. Aerogen's mission is to develop and commercialize innovative inhalation technologies that improve the delivery of inhaled medications to patients.
Aerogen's technology is based on the principle of mesh nebulization. Mesh nebulization is a process that uses a vibrating mesh to create a fine mist of aerosol particles. This mist is then inhaled by the patient. Aerogen's mesh nebulizers are designed to be small, portable, and easy to use. They are also designed to deliver a consistent dose of medication to the patient over time.
Aerogen's products are used to treat a variety of respiratory diseases, including asthma, COPD, and cystic fibrosis. The company's products are also used to deliver other medications, such as pain relievers and antibiotics.
Aerogen has been recognized for its innovative work. In 2016, the company was awarded the Frost & Sullivan Global Respiratory Drug Delivery Technology Innovation Award. Aerogen is also a member of the Irish Medical Technology Association.
Aerogen is a global company with headquarters in Galway, Ireland. The company has operations in the United States, Europe, and Asia. Aerogen's products are sold in over 70 countries.
Aerogen's success is a testament to the talent of its founders and employees. The company's commitment to innovation has made it a leader in the development of inhalation drug delivery systems. Aerogen's products are helping to improve the lives of patients around the world.